1. Home
  2. XENE vs REVG Comparison

XENE vs REVG Comparison

Compare XENE & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • REVG
  • Stock Information
  • Founded
  • XENE 1996
  • REVG 2008
  • Country
  • XENE Canada
  • REVG United States
  • Employees
  • XENE N/A
  • REVG N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • REVG Auto Manufacturing
  • Sector
  • XENE Health Care
  • REVG Consumer Discretionary
  • Exchange
  • XENE Nasdaq
  • REVG Nasdaq
  • Market Cap
  • XENE 2.4B
  • REVG 2.2B
  • IPO Year
  • XENE 2014
  • REVG 2017
  • Fundamental
  • Price
  • XENE $32.63
  • REVG $48.39
  • Analyst Decision
  • XENE Strong Buy
  • REVG Hold
  • Analyst Count
  • XENE 11
  • REVG 4
  • Target Price
  • XENE $54.82
  • REVG $41.25
  • AVG Volume (30 Days)
  • XENE 1.5M
  • REVG 682.3K
  • Earning Date
  • XENE 08-07-2025
  • REVG 09-03-2025
  • Dividend Yield
  • XENE N/A
  • REVG 0.49%
  • EPS Growth
  • XENE N/A
  • REVG N/A
  • EPS
  • XENE N/A
  • REVG 1.86
  • Revenue
  • XENE $7,500,000.00
  • REVG $2,331,500,000.00
  • Revenue This Year
  • XENE N/A
  • REVG $3.60
  • Revenue Next Year
  • XENE $253.71
  • REVG $6.89
  • P/E Ratio
  • XENE N/A
  • REVG $26.04
  • Revenue Growth
  • XENE N/A
  • REVG N/A
  • 52 Week Low
  • XENE $26.74
  • REVG $21.54
  • 52 Week High
  • XENE $46.00
  • REVG $50.34
  • Technical
  • Relative Strength Index (RSI)
  • XENE 51.18
  • REVG 65.57
  • Support Level
  • XENE $31.22
  • REVG $48.03
  • Resistance Level
  • XENE $33.51
  • REVG $50.34
  • Average True Range (ATR)
  • XENE 1.18
  • REVG 1.23
  • MACD
  • XENE 0.04
  • REVG -0.11
  • Stochastic Oscillator
  • XENE 45.62
  • REVG 72.02

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About REVG REV Group Inc.

REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.

Share on Social Networks: